Sarasin & Partners LLP Cuts Position in Healthpeak Properties, Inc. $DOC

Sarasin & Partners LLP cut its holdings in Healthpeak Properties, Inc. (NYSE:DOC) by 34.4% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 82,206 shares of the real estate investment trust’s stock after selling 43,136 shares during the period. Sarasin & Partners LLP’s holdings in Healthpeak Properties were worth $1,759,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently modified their holdings of DOC. WPG Advisers LLC increased its position in shares of Healthpeak Properties by 270.2% during the 4th quarter. WPG Advisers LLC now owns 1,640 shares of the real estate investment trust’s stock valued at $26,000 after purchasing an additional 1,197 shares during the last quarter. Advocate Investing Services LLC purchased a new position in shares of Healthpeak Properties in the 4th quarter worth about $26,000. Elyxium Wealth LLC bought a new position in Healthpeak Properties during the fourth quarter valued at about $31,000. Clearstead Advisors LLC grew its position in Healthpeak Properties by 166.3% during the fourth quarter. Clearstead Advisors LLC now owns 1,947 shares of the real estate investment trust’s stock valued at $31,000 after buying an additional 1,216 shares during the period. Finally, CYBER HORNET ETFs LLC purchased a new stake in Healthpeak Properties during the second quarter worth about $33,000. 93.57% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several analysts have commented on DOC shares. Evercore lowered shares of Healthpeak Properties from an “outperform” rating to an “in-line” rating and set a $21.00 price objective on the stock. in a research report on Monday, May 11th. JPMorgan Chase & Co. raised their price target on shares of Healthpeak Properties from $18.00 to $21.00 and gave the stock a “neutral” rating in a research note on Wednesday, June 24th. Raymond James Financial assumed coverage on shares of Healthpeak Properties in a report on Wednesday, June 17th. They issued a “market perform” rating on the stock. Mizuho increased their price objective on Healthpeak Properties from $21.00 to $24.00 and gave the company an “outperform” rating in a report on Monday, July 6th. Finally, Morgan Stanley reissued an “equal weight” rating and issued a $22.00 target price (up from $20.00) on shares of Healthpeak Properties in a research report on Thursday, June 11th. Four equities research analysts have rated the stock with a Buy rating and fifteen have given a Hold rating to the stock. According to MarketBeat, Healthpeak Properties currently has an average rating of “Hold” and a consensus price target of $20.97.

Healthpeak Properties Price Performance

Shares of NYSE:DOC opened at $21.10 on Friday. The firm has a market capitalization of $14.55 billion, a PE ratio of 60.30, a P/E/G ratio of 3.37 and a beta of 1.01. The company has a quick ratio of 2.96, a current ratio of 3.02 and a debt-to-equity ratio of 1.06. The company has a 50-day moving average price of $21.15 and a two-hundred day moving average price of $18.78. Healthpeak Properties, Inc. has a twelve month low of $15.70 and a twelve month high of $22.95.

Healthpeak Properties (NYSE:DOC) last posted its quarterly earnings results on Tuesday, August 4th. The real estate investment trust reported $0.08 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.03 by $0.05. The company had revenue of $771.58 million for the quarter, compared to analyst estimates of $725.64 million. Healthpeak Properties had a net margin of 8.24% and a return on equity of 2.79%. The company’s quarterly revenue was up 11.1% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.46 earnings per share. Healthpeak Properties has set its FY 2026 guidance at 1.730-1.770 EPS. Equities analysts forecast that Healthpeak Properties, Inc. will post 1.76 EPS for the current year.

Healthpeak Properties Announces Dividend

The firm also recently announced a monthly dividend, which will be paid on Friday, September 25th. Shareholders of record on Monday, September 14th will be issued a dividend of $0.1017 per share. The ex-dividend date of this dividend is Monday, September 14th. This represents a c) dividend on an annualized basis and a yield of 5.8%. Healthpeak Properties’s payout ratio is presently 348.57%.

Insider Activity

In other Healthpeak Properties news, insider Scott R. Bohn sold 10,989 shares of the stock in a transaction on Tuesday, May 12th. The stock was sold at an average price of $19.45, for a total transaction of $213,736.05. Following the sale, the insider owned 7,636 shares in the company, valued at $148,520.20. This represents a 59.00% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. 0.23% of the stock is currently owned by corporate insiders.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.